Halozyme Therapeutics Inc (NASDAQ:HALO)

16.05
Delayed Data
As of Oct 11
 +0.41 / +2.62%
Today’s Change
13.24
Today|||52-Week Range
18.10
+9.71%
Year-to-Date
No recent news for Halozyme Therapeutics Inc.

Today’s Trading

Previous close15.64
Today’s open15.75
Day’s range15.64 - 16.10
Volume1,498,525
Average volume (3 months)832,982
Market cap$2.3B
Data as of 4:15pm ET, 10/11/2019

Growth & Valuation

Earnings growth (last year)-221.61%
Earnings growth (this year)+36.35%
Earnings growth (next 5 years)+55.00%
Revenue growth (last year)-52.04%
P/E ratioNM
Price/Sales13.83
Price/Book9.34

Competitors

 Today’s
change
Today’s
% change
IOVAIovance Biotherapeut...+0.11+0.61%
ZLABZai Lab Ltd+0.03+0.09%
XLRNAcceleron Pharma Inc+1.10+2.87%
TLRYTilray Inc+0.31+1.50%
Data as of 4:00pm ET, 10/11/2019

Financials

Next reporting dateNovember 5, 2019
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$151.9M
Annual profit (last year)-$80.3M
Net profit margin-52.90%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts